E. Morel-Chany

631 total citations · 1 hit paper
9 papers, 538 citations indexed

About

E. Morel-Chany is a scholar working on Biotechnology, Hepatology and Oncology. According to data from OpenAlex, E. Morel-Chany has authored 9 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Biotechnology, 4 papers in Hepatology and 2 papers in Oncology. Recurrent topics in E. Morel-Chany's work include Cancer Research and Treatments (4 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (2 papers). E. Morel-Chany is often cited by papers focused on Cancer Research and Treatments (4 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (2 papers). E. Morel-Chany collaborates with scholars based in France. E. Morel-Chany's co-authors include A. Guillouzo, Christiane Guguen‐Guillouzo, Georges Baffet, Bruno Clément, Denise Glaise, Marie‐France Szajnert, C. Lafarge‐Frayssinet, C Frayssinet and P Burtin and has published in prestigious journals such as Experimental Cell Research, Carcinogenesis and Cancer Letters.

In The Last Decade

E. Morel-Chany

9 papers receiving 519 citations

Hit Papers

Maintenance and reversibility of active albumin secretion... 1983 2026 1997 2011 1983 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Morel-Chany France 6 300 202 141 133 101 9 538
E. Alexandre France 8 159 0.5× 152 0.8× 115 0.8× 109 0.8× 51 0.5× 10 414
Tessa V. van der Hoeven Netherlands 11 184 0.6× 176 0.9× 38 0.3× 144 1.1× 94 0.9× 14 382
Linda J. Loretz United States 9 81 0.3× 177 0.9× 61 0.4× 175 1.3× 11 0.1× 9 493
Ulrike Assmus Germany 6 134 0.4× 76 0.4× 67 0.5× 126 0.9× 5 0.0× 7 470
Mohsin Hassan Germany 11 99 0.3× 57 0.3× 27 0.2× 121 0.9× 18 0.2× 20 314
Muhammad Massarwa Israel 7 93 0.3× 54 0.3× 16 0.1× 114 0.9× 29 0.3× 14 386
Laurie P. Peiffer United States 12 46 0.2× 96 0.5× 9 0.1× 160 1.2× 11 0.1× 24 436
Xiaohui Ye China 9 89 0.3× 37 0.2× 14 0.1× 110 0.8× 24 0.2× 24 324
Sheetalnath Rooge India 12 134 0.4× 63 0.3× 23 0.2× 142 1.1× 19 0.2× 27 433
E. Löser Germany 9 153 0.5× 43 0.2× 49 0.3× 95 0.7× 2 0.0× 16 478

Countries citing papers authored by E. Morel-Chany

Since Specialization
Citations

This map shows the geographic impact of E. Morel-Chany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Morel-Chany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Morel-Chany more than expected).

Fields of papers citing papers by E. Morel-Chany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Morel-Chany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Morel-Chany. The network helps show where E. Morel-Chany may publish in the future.

Co-authorship network of co-authors of E. Morel-Chany

This figure shows the co-authorship network connecting the top 25 collaborators of E. Morel-Chany. A scholar is included among the top collaborators of E. Morel-Chany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Morel-Chany. E. Morel-Chany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Morel-Chany, E., et al.. (1985). Progression of spontaneous malignant transformation of epithelial rat liver cell lines. Cell Biology and Toxicology. 1(2). 11–22. 6 indexed citations
3.
Lafarge‐Frayssinet, C., et al.. (1983). Promoting effect of biliverdin for liver cells initiated by aflatoxin B1. Cancer Letters. 18(3). 277–282. 5 indexed citations
4.
Guguen‐Guillouzo, Christiane, Bruno Clément, Georges Baffet, et al.. (1983). Maintenance and reversibility of active albumin secretion by adult rat hepatocytes co-cultured with another liver epithelial cell type. Experimental Cell Research. 143(1). 47–54. 436 indexed citations breakdown →
5.
Lafarge‐Frayssinet, C., et al.. (1981). Enhancement of DNA synthesis by biliverdin in a non-transformed liver cell strain.. PubMed. 27(2-3). 77–82. 5 indexed citations
6.
Morel-Chany, E., et al.. (1981). Cytotoxic and cytostatic effect of T2-toxin on epithelial cell lines derived from rat liver.. PubMed. 3(3). 125–9. 1 indexed citations
7.
Morel-Chany, E., et al.. (1980). Cytostatic effects of T2 toxin on cultured human neoplastic cells of intestinal origin.. PubMed. 67(2). 149–54. 9 indexed citations
8.
Morel-Chany, E., et al.. (1979). Effects of PR toxin on liver cells in culture. Toxicology. 12(3). 313–323. 9 indexed citations
9.
Morel-Chany, E., et al.. (1978). “Spontaneous” neoplastic transformation in vitro of epithelial cell strains of rat liver: Cytology, growth and enzymatic activities. European Journal of Cancer (1965). 14(12). 1341–1352. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026